Post by PressReleaseon Jan 03, 2023 7:00am
53 Views
Post# 35200165
New Press Release - Algernon Pharmaceuticals Forms Private Subsidiary to Advance Company's Psychedelic DMT Stroke Program; Files Form 1-A Offering Statement with U.S. SEC for Regulation A+ Offering